← Browse by Condition
Medical Condition

ovarian cancer recurrent

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07030907 Phase 1
Recruiting

A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer

Enrollment
30 pts
Location
United States
Sponsor
Outpace Bio, Inc.
View Trial →